TrialJournal of translational medicine2022

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.

Evgeny Bazdyrev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.